The commercial applications of polymers produced by reversible-deactivation radical polymerization are reviewed here.
No takes yet. Share an insight, caveat, or question.
Mathias Destarac (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: